Molecular complexes of aspirin with humic acid extracted from shilajit and their characterization

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 67, Issue 1-2, 2010, Pages 209-215

  Anwer, Md Khalid ^a,b   Agarwal, Suraj P ^a   Ali, Asgar ^a   Sultana, Yasmin ^a  

^a HAMDARD UNIVERSITY   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Aspirin; Bioavailability; Characterization; Humic acid; Shilajit; Stability

Indexed keywords

EID: 77952319596     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-009-9699-2     Document Type: Article

References (20)

1. Frawley, D., Lad, V.: The Yoga of Herbs, 2nd edn, p. 250. Lotus Press, Twin Lakes (2001).
2. Chopra, R. A., Chopra, I. C., Handa, K. L.: Indigenous Drugs of India, pp. 457-461. U. N. Dhar and Sons, Calcutta (1958).
3. Ghosal, S.: Shilalit: its origin and significance. Indian J. Indig. Med. 9, 1-3 (1992).
4. Agarwal, S. P., Aqil, M., Anwer, M. K.: Enhancement of the dissolution and diuretic effect of furosemide through a novel complexation with humic acid extracted from shilajit. Asian J. Chem. 19, 4711-4718 (2007).
5. Khanna, R., Witt, M., Anwer, M. K., Agarwal, S. P., Koch, B. P.: Spectroscopic characterization of fulvic acids extracted from the rock exudate shilajit. Org. Geochem. 39, 1719-1724 (2008).
6. Ghosal, S.: Shilajit in Perspective, pp. 1-8. Narosa Publishing, New Delhi (2006).
7. Agarwal, S. P., Khanna, R., Karmarkar, R., Anwer, M. K., Khar, R.: Shilajit: A Review. Phytother. Res. 21, 401-405 (2007).
8. Ghosal, S., Singh, S. K., Kumar, Y., Srivastava, R. S., Goel, R. K., Dey, R., Bhattacharya, S. K.: Shilajit: Part 3. Anti-ulcerogenic activity of fulvic acids and 4-methoxy-6-carbomethoxybiphenyl isolated from shilajit. Phytother. Res. 2, 187-191 (1988).
9. Ghosal, S., Singh, S. K., Srivastava, R. S.: Shilajit: Part 2. Biphenyl metabolites from Trifolium repens. J. Chem. Res. 5, 196-197 (1988).
10. Ghosal, S.: Delivery system for pharmaceutical, nutritional and cosmetic ingredients. US Patent 6, 558, 712, 2003.
11. Agarwal, S. P., Aqil, M., Anwer, M. K.: Complexation of furosemide with fulvic acid extracted from shilajit: a novel approach. Drug Dev. Ind. Pharm. 34, 506-511 (2008).
12. Khanna, R.: Bioenhancers from natural sources. Ph. D Thesis, Jamia Hamdard, New Delhi (2006).
13. Karmarkar, R. R.: New bioavailability enhancers from natural sources. Ph. D Thesis, Jamia Hamdard, New Delhi (2007).
14. Chang, R. K., Whitworth, C. W.: Aspirin degradation in mixed polar solvents. Drug Dev. Ind. Pharm. 10, 515-526 (1984).
15. Gore, A. Y., Maik, K. B., Kildsig, D. O., Peck, G. E., Smolen, V. F., Banker, G. S.: Significance of salicylic acid sublimation in stability testing of aspirin-containing solids. J. Pharm. Sci. 57, 1850-1854 (1968).
16. Mario, E., Gerraughty, R. J.: Effect of ultrasound energy on hydrolysis of aspirin. J. Pharm. Sci. 54, 321-323 (1965).
17. Ghosal, S.: In: Vohara, S. B., Dandiya, P. C. (eds.) Research and Development of Indigenous Drugs, pp. 72-80. Institute of History of Medicine and Medical Research, New Delhi (1989).
18. Choi, H. S.: Molecular inclusion complexes: cyclodextrins and benzaldehyde; cyclodextrins and acetylsalicylic acid. Ph. D Thesis, Purdue University, WL, IN, USA (1989).
19. Shay, H., Komarow, S. A., Fels, S. S., Meranze, D., Gruenstein, M., Siplet, H. A.: Simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 5, 43 (1945).
20. Takagi, K., Okabe, S.: Prevention of gastric lesions. US Patent 3, 988, 466, 1976.